Cryo-Cell International Q3 EPS $0.08 Vs. $0.06 Prior Year, Sales $7.87M Beat $7.77M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cryo-Cell International (NASDAQ:CCEL) reported Q3 earnings of $0.08 per share, a 33.33% increase from the same period last year. The company's quarterly sales of $7.87 million beat the analyst consensus estimate of $7.77 million by 1.29%, marking a 2.21% increase over sales from the same period last year.
October 12, 2023 | 8:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cryo-Cell International's Q3 earnings and sales exceeded expectations, indicating a positive financial performance.
Cryo-Cell International reported higher than expected earnings and sales for Q3. This indicates a strong financial performance and could potentially lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100